| TELIX PHARMACEUTICALS LTD |
| Australien |
| Gesundheit |
| AU000000TLX2 / A2H7JK |
| T3X (Frankfurt) |
| FRA:T3X, ETR:T3X, T3X:GR |
| - |
| https://telixpharma.com/ |
|
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on developing and commercializing therapeutic and diagnostic radiopharmaceuticals. Its portfolio is centered on cancer care, with products and programs designed to ..
>Volltext.. |
| 3276.16 Mio. EUR |
| 3561.91 Mio. EUR |
| 805.3 Mio. EUR |
| 27.77 Mio. EUR |
| 29 Mio. EUR |
| 0.09 EUR |
| 514.36 Mio. EUR |
| 223.45 Mio. EUR |
| -13.26 Mio. EUR |
| 1.04 |
| 37.44% |
| 207.47% |
| - |
| - |
| - |
| - |
| TELIX |
| 07.10.26 |
|